Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Evaxion A/S changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 10 | 9 | −1 |
| Shares | 1.35M | 1.33M | −17.3K (−1.3%) |
| Value | $2.50M | $3.27M | +$768.3K (+30.7%) |
New holders (0)
Institutions that held Evaxion A/S at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (1)
Institutions that held Evaxion A/S at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| XTX Topco Ltd | 16,281 | $30.1K |